Page 53 - THE PERCEPT STUDY Illness Perceptions in Physiotherapy Edwin de Raaij

A systematic literature review
51
3
Table 3: Study characteristics
Study
Condition
Study Sample
Study Design
IP
Pain
Physical Function
Comments
Scharloo et al50 Scharloo et al51
RA, 12.0 ± 8.2 y RA, 12.4 ± 8.5 y
n = 84; 51.7 ± 12.6 y; 75% female
Cross-sectional Longitudinal
IPQ IPQ
SF-20, HAQ HAQ
SF-20: higher score, fewer limitations; HAQ: higher score, more limitations
Groarke et al18
RA, 12.6 ± 10.8 y
n = 75 at baseline and n = 52 at follow-up; 60.1 ± 12.1y;100% female
Cross-sectional, longitudinal
IPQ
AIMS
Time interval, 12 and 24 mo
AIMS: higher score, more pain and more limitations
Goodman et al17
Systemic lupus erythematosus
n = 11; age and sex unknown
Longitudinal
IPQ-R
IPQ-R
IPQ-R AIMS IPQ-R
Brief IPQ
IPQ-R
IPQ-R NRS
SF-36 SF-36 AIMS SF-36 SF-36 RMDQ
Time interval, 7 wk
SF-36: higher score, fewer limitations
Stuifbergen et al55
Fibromyalgia, >1 y
n = 160; 18-75 y; 100% female
Cross-sectional
SF-36: higher score, fewer limitations
Hill et al26
Musculoskeletal hand problems (chronic)
n = 2113; 65.4 ± 9.6 y; 63% female
Cross-sectional
AIMS: higher score, more pain and more limitations
Moss-Morris et al42
Chronic pain, 7.1 ± 6.9 y
n = 98; 42.4 ± 9.5 y; 65% female
Longitudinal
Time interval, 4 wk
SF-36: higher score, fewer limitations
Sluiter and Frings- Dresen54
Chronic RSI, 5.8 ± 3.2 y
n = 1121; 40.8 ± 8.7 y; 67% female
Cross-sectional
SF-36, VAS
VAS: higher score, more pain; SF-36:higher score, less pain and fewer limitations
Foster et al12
LBP, >1 mo to <3 y
n = 1591; 43.9 ± 10.3 y; 59% female
Longitudinal
Time interval, 6 mo
RMDQ: higher score, fewer limitations
van Wilgen et al57
Fibromyalgia, about 10 y
n = 51; 44.0 ± 10.0 y; 92% female
Cross-sectional
NRS: higher score, more pain
Broadbent et al4 Chaboyer et al8
Persistent headache Injury (acute)
n = 65; age and sex
Cross-sectional Longitudinal
Brief IPQ IPQ-R
NRS
NRS: higher score, more pain
Patient Characteristics
Measurement Instruments
n = 71; 52.2 ± 12.2 y; 75% female
VAS AIMS
Time interval, 12 ± 2 mo
VAS: higher score, more pain; HAQ: higher score, more limitations
n = 114; <45 y, 24%; 33% female
SF-36
Time interval, 6 mo
SF-36: higher score, fewer limitations